Safeguard Scientifics, Inc.

SFES • Asset Management

$0.51

— 0.00 (0.00%)

EarningsLatest report: Mar 31, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$8.53M

Growth

-100.0%

Cash Flow

0/5

Trend

Negative

Evidence

Reasonable earnings multiple · 8.05Manageable debt level · 0.02Healthy liquidity · 10.06Weak profitability

Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 26, 2026, 12:18 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.51

Change0.00%

Shares Out16.72M

Market Cap$8.53M

Enterprise Value$-20.04M

52W Range0.22 - 1.89

Beta-0.92

P/E0.41

P/B0.29

P/FCF-2.45

EV/EBITDA68.63

EV/FCF5.76

Price$0.51

Change0.00%

Shares Out16.72M

Market Cap$8.53M

Enterprise Value$-20.04M

52W Range0.22 - 1.89

Beta-0.92

P/E0.41

P/B0.29

P/FCF-2.45

EV/EBITDA68.63

EV/FCF5.76

Earnings Yield244.33%

FCF Yield-40.78%

Dividend Yield0.00%

Gross Margin0.00%

Oper. Margin0.00%

Profit Margin0.00%

Debt/Eq0.02

Current Ratio10.06

Quick Ratio10.06

Revenue 5Y-100.00%

Volume100.00

Avg Volume3.33K

EPS Surprise1.44

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

22/100

Financial Strength

Debt, cash, stability

76/100

Growth Potential

Revenue and expansion

50/100

Price Attractiveness

Cheap or expensive today

94/100

Why this score▼

Reasonable earnings multiple · 8.05Manageable debt level · 0.02Healthy liquidity · 10.06Weak profitability

Analyst view

No analyst data available now.

Company Overview

IPO: 3/17/1980

Industry: Asset Management

P/B i: 0.29

Debt / Equity i: 0.02

Operating Margin: 0.00%

Net Margin: 0.00%

ROE i: -

ROIC: -

Financial Health

Score15 / 20

Debt / Equity: 0.02

Current Ratio: 10.06

Quick Ratio: 10.06

Status: Good

Insider Transactions

Recent executive and insider activity

StepStone Group Holdings LLC

Transaction: 12/06/2013

SELL

Change

—

Price

Not reported

Filing

12/10/2013

Type

SELL

StepStone Group Holdings LLC

Transaction: 12/06/2013

BUY

Change

+5,611,555

Price

Not reported

Filing

12/10/2013

Type

BUY

StepStone Group Holdings LLC

Transaction: 09/03/2013

OPTION

Change

+5,611,555

Price

Not reported

Filing

12/10/2013

Type

OPTION

Insider	Type	Change	Price	Transaction	Filing
StepStone Group Holdings LLC	SELL	—	Not reported	12/06/2013	12/10/2013
StepStone Group Holdings LLC	BUY	+5,611,555	Not reported	12/06/2013	12/10/2013
StepStone Group Holdings LLC	OPTION	+5,611,555	Not reported	09/03/2013	12/10/2013
StepStone Group Holdings LLC	OPTION	0	Not reported	09/03/2013	12/10/2013
SLATTERY JOSEPH P	OPTION	+250,000	$0.40	10/02/2013	10/03/2013
SLATTERY JOSEPH P	BUY	+1,000,000	Not reported	10/02/2013	10/03/2013
Milne David Bruce	OTHER	0	Not reported	09/03/2013	09/11/2013
LAVIOLETTE PAUL A	SELL	-28,832	$0.07	09/03/2013	09/11/2013
SVLSF IV, LLC	OPTION	+11,549,790	$0.40	09/03/2013	09/11/2013
SVLSF IV, LLC	SELL	0	Not reported	09/03/2013	09/11/2013
StepStone Group Holdings LLC	OPTION	0	Not reported	09/03/2013	09/11/2013
AISLING CAPITAL III LP	BUY	—	$0.40	09/03/2013	09/05/2013
Dougherty Dennis	BUY	+598,706	$0.40	09/03/2013	09/05/2013
SYNERGY LIFE SCIENCE PARTNERS L P	BUY	—	$0.40	09/03/2013	09/05/2013
FROST PHILLIP MD ET AL	BUY	+742,000	$0.40	09/03/2013	09/05/2013
Dougherty Dennis	OPTION	0	Not reported	09/03/2013	09/04/2013
Kherani Aftab	OTHER	0	Not reported	09/03/2013	09/04/2013
AISLING CAPITAL III LP	OPTION	0	Not reported	09/03/2013	09/04/2013
SYNERGY LIFE SCIENCE PARTNERS L P	SELL	0	Not reported	09/03/2013	09/04/2013
Martin James Joseph	BUY	+70,000	$0.45	04/23/2013	04/25/2013

About the Company

Safeguard Scientifics, Inc.

Safeguard Scientifics, Inc., a former private equity and venture capital firm, is no longer actively seeking new investments. Historically, the firm specialized in a broad range of financing activities, including providing capital for company expansion and growth, facilitating management buyouts, executing recapitalizations, driving industry consolidations, and supporting corporate spin-offs. Their investment scope covered both early and growth-stage companies. Typically, Safeguard Scientifics participated in Series A, B, or C funding rounds, with an opportunistic approach to seed-stage investments. Their primary sector focus spanned technology, financial services, and healthcare. Within the technology sphere, their interests were diverse, encompassing areas such as software-as-a-service (SaaS), adtech, digital media, the Internet of Everything (IoE), advanced security solutions, predictive analytics, machine learning, artificial intelligence, enterprise software, technology-enabled services, internet/new media, financial technology (FinTech), cloud computing, mobile, social platforms, big data, in-memory computing, and select business services. For these tech ventures, they considered companies requiring up to $25 million in capital. In the healthcare sector, the firm directed its investments towards molecular and point-of-care diagnostics, various medical devices, regenerative medicine, broader medical technology, digital health solutions, healthcare technology, specialized pharmaceuticals, and chosen healthcare services. Geographically, Safeguard Scientifics invested across the entire United States, with a particular emphasis on the Mid-Atlantic region, and also extended its reach into Southeastern Canada. Financial commitments for growth equity financing generally ranged from $5 million to $25 million, while early-stage financings typically saw investments between $5 million and $10 million. The firm's investment strategy often targeted a variety of capital structures, including self-funded (bootstrapped) companies, corporate divisions or business units, and venture capital-backed entities seeking a growth partner. Safeguard Scientifics aimed to be the largest stakeholder in its portfolio companies, typically acquiring an ownership stake between 20% and 50%, though they were flexible and might occasionally take either a majority or a smaller interest. A strong preference existed for companies possessing proprietary technology and intellectual property. Furthermore, the firm routinely sought a Board seat in its invested companies. Founded in 1953 as Lancaster Corporation, the company adopted the name Safeguard Scientifics, Inc. in 1981. Its main office is located in Radnor, Pennsylvania, with an additional presence in Weston, Massachusetts.

Source - link

Peers

AHFCF BLRZF HCGI MATEF MONTF PIAC PRPS RHCO SNTX TRRPF

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

📰

No news available now

Check back later.

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-15	-0.34	1.1	1.44
2026-03-31	-0.29	-0.02	0.27
2021-03-03	-0.27	-0.35	-0.08
2020-11-05	-0.29	-0.21	0.08
2020-08-11	-0.33	-0.48	-0.15
2020-04-30	-0.34	-0.77	-0.43
2020-02-27	-0.39	-0.03	0.36
2019-11-07	-0.545	-0.12	0.425
2013-10-24	-0.54	-0.9	-0.36
2013-07-25	-0.45	-1.33	-0.88
2013-04-25	-0.39	-0.57	-0.18
2013-03-07	-0.23	-0.51	-0.28